pharma.markets

  • HOME
  • Imprint

covid19

FDA COVID-19 Alert: Beware of Misleading Registration Certificates

03/03/2021 MaP 0

How to tell if a device is approved, cleared, or authorized by the FDA During the COVID-19 pandemic, some companies are selling medical devices (including […]

Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants

25/02/2021 MaP 0

The evaluation is part of the Phase 1/2/3 trial and will study a third dose of the Pfizer-BioNTech COVID-19 vaccine, BNT162b2, at 30 µg that […]

In Vitro Study Published in The New England Journal of Medicine

17/02/2021 MaP 0

Demonstrates Sera from Individuals Immunized with the Pfizer-BioNTech COVID-19 Vaccine Neutralize SARS-CoV-2 with South African Variant Spike Mutations Pfizer Inc. (NYSE: PFE) and BioNTech SE […]

Pfizer and BioNTech Publish Data from In Vitro Studies

08/02/2021 MaP 0

….in Nature Medicine Demonstrating COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants Pfizer Inc. (NYSE: PFE) […]

pharma.markets bygigis.com

Covid19 Vaccine Europe stats 2.2.2021

04/02/2021 MaP 0

EU boosts humanitarian aid budget for 2021 as needs rise

26/01/2021 MaP 0

As global humanitarian needs worsen further due to the consequences of the coronavirus pandemic and the effects of climate change, the European Commission has adopted […]

Comunidad Valencia 23.1.2021 Covid19

23/01/2021 MaP 0

The Comunitat Valenciana has recorded 6,122 new cases of coronavirus confirmed by PCR or antigen testing since the last update, bringing the total number of […]

Source: CDC/Alissa Eckert, MS; Dan Higgins, MAMS

Safety of COVID-19 Vaccines – Paul-Ehrlich Institut

21/01/2021 MaP 0

In Germany, the Paul-Ehrlich-Institut is the authority responsible for monitoring the safety of vaccines and biomedicines. For this purpose, the institute’s Division Pharmacovigilance collects and […]

An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation

08/01/2021 MaP 0

Associated with Rapid Transmission Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and […]

CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV

07/01/2021 MaP 0

Companies enter into a collaboration and services agreement Bayer to support CureVac in numerous areas, including development and supply of CVnCoV CureVac benefits from Bayer´s […]

BioNTech Recognizes Employees and Partners for Their Support in Developing Historic Vaccine

31/12/2020 MaP 0

BioNTech SE (Nasdaq: BNTX) today wants to express its thanks and gratitude not only to its employees but also to the many partners who have […]

photo NIAID

Vaccine roll-out to begin, thanks to the EU Strategy for COVID-19 vaccines

15/12/2020 MaP 0

Sandra Gallina, Director General of the European Commission’s Directorate General for Health and Food Safety, talks about the imminent roll-out of COVID-19 vaccines. The EU […]

Posts navigation

1 2 3 »

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Animal health
  • Asthma
  • Cancer
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • UN
  • Vaccines

Reports

  • FDA COVID-19 Alert: Beware of Misleading Registration Certificates
  • Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines
  • Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine
  • Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
  • EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries

Archive

  • March 2021 (2)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • FDA COVID-19 Alert: Beware of Misleading Registration Certificates

    03/03/2021 0
  • Biden Administration Announces Historic Manufacturing Collaboration Between Merck and Johnson & Johnson to Expand Production of COVID-19 Vaccines

    03/03/2021 0
  • Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine

    25/02/2021 0
  • Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants

    25/02/2021 0
  • Copyright European Commission 2021

    EU doubles contribution to COVAX to €1 billion to ensure safe and effective vaccines for low and middle-income countries

    20/02/2021 0
Archives
  • March 2021 (2)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid biontech cancer commission companies coronavirus covid-19 covid19 crisis economy elpais.com eu europe european fda fight food global guarantee health hygiene italy links medical merck novartis pandemic pfizer production products recommendations region response roche safety scheme sector spain state statistics stats support vaccine

Copyright © 2021 | WordPress Theme by MH Themes